Clinical Trial Update: Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking [Phase 3]

View source ↗

Summary

Phase 3 study comparing nicotine inhaler and bupropion for smoking cessation and relapse prevention in individuals with lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Nicotine inhaler (nicotine inhaler)
• bupropion (bupropion)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED